Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Bernard

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Electrophysiology|January 9, 2020
Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery diseasePeter G Pantlin, Robert M Bober, Michael L Bernard, et al.
Journal of Cardiovascular Electrophysiology|September 7, 2022
Sacubitril/valsartan: An antiarrhythmic drug?Elaine Huang, Michael L Bernard, A Elise Hiltbold, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 2, 2020
Utility of serial measurement of biomarkers of cardiovascular stress and inflammation in systolic dysfunctionDaniel P Morin, Ronald Chong-Yik, Sudarone Thihalolipavan, et al.
Clinical Biochemistry|December 20, 2024
Serial secretoneurin measurement and risk of ventricular arrhythmias and death in patients with left ventricular systolic dysfunctionTorbjørn Omland, Helge Røsjø, Torbjørn Wisløff, et al.
Clinical Cardiology|October 8, 2015
Natural History and Implantable Cardioverter-Defibrillator Implantation After Revascularization for Stable Coronary Artery Disease With Depressed Ejection FractionGeoffrey F Lewis, Adam C Harless, Lauren Vazquez, et al.
The Journal of Biological Chemistry|April 30, 2003
Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alphaJoe B Blumer, Michael L Bernard, Yuri K Peterson, et al.
Heart Rhythm|May 23, 2015
T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathyTodd M Rosenthal, Paul F Stahls, Freddy M Abi Samra, et al.
Journal of Consulting and Clinical Psychology|August 31, 2011
Mindfulness is associated with fewer PTSD symptoms, depressive symptoms, physical symptoms, and alcohol problems in urban firefightersBruce W Smith, J Alexis Ortiz, Laurie E Steffen, et al.
Progress in Cardiovascular Diseases|August 1, 2021
The role of atrial fibrillation catheter ablation in patients with heart failureMichael L Bernard, Francis Benn, Cody M Williams, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Optimal method of measuring the T-peak to T-end interval for risk stratification in primary preventionTodd M Rosenthal, Daniel Masvidal, Freddy M Abi Samra, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Electrophysiology|January 9, 2020
Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery diseasePeter G Pantlin, Robert M Bober, Michael L Bernard, et al.
Journal of Cardiovascular Electrophysiology|September 7, 2022
Sacubitril/valsartan: An antiarrhythmic drug?Elaine Huang, Michael L Bernard, A Elise Hiltbold, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 2, 2020
Utility of serial measurement of biomarkers of cardiovascular stress and inflammation in systolic dysfunctionDaniel P Morin, Ronald Chong-Yik, Sudarone Thihalolipavan, et al.
Clinical Biochemistry|December 20, 2024
Serial secretoneurin measurement and risk of ventricular arrhythmias and death in patients with left ventricular systolic dysfunctionTorbjørn Omland, Helge Røsjø, Torbjørn Wisløff, et al.
Clinical Cardiology|October 8, 2015
Natural History and Implantable Cardioverter-Defibrillator Implantation After Revascularization for Stable Coronary Artery Disease With Depressed Ejection FractionGeoffrey F Lewis, Adam C Harless, Lauren Vazquez, et al.
The Journal of Biological Chemistry|April 30, 2003
Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alphaJoe B Blumer, Michael L Bernard, Yuri K Peterson, et al.
Heart Rhythm|May 23, 2015
T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathyTodd M Rosenthal, Paul F Stahls, Freddy M Abi Samra, et al.
Journal of Consulting and Clinical Psychology|August 31, 2011
Mindfulness is associated with fewer PTSD symptoms, depressive symptoms, physical symptoms, and alcohol problems in urban firefightersBruce W Smith, J Alexis Ortiz, Laurie E Steffen, et al.
Progress in Cardiovascular Diseases|August 1, 2021
The role of atrial fibrillation catheter ablation in patients with heart failureMichael L Bernard, Francis Benn, Cody M Williams, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Optimal method of measuring the T-peak to T-end interval for risk stratification in primary preventionTodd M Rosenthal, Daniel Masvidal, Freddy M Abi Samra, et al.
Pageof 3